Mersana Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference

CAMBRIDGE, Mass.--()--Mersana Therapeutics, Inc., today announced that Anna Protopapas, President and Chief Executive Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace Hotel on Wednesday, November 30, 2016, at 12:10 p.m. ET.

About Mersana Therapeutics

Mersana Therapeutics engineers antibody-drug conjugates (ADCs) that maximize the potential of new and established therapeutic classes. Mersana is developing, with select pharmaceutical partners, a portfolio of next-generation Fleximer® ADCs with superior properties not found with current ADC technologies. The company is also advancing its own pipeline of Fleximer-ADCs with best-in-class potential to address unmet needs and improve patient outcomes in multiple oncology indications.

Contacts

Media Contact
For Mersana Therapeutics
Paul Kidwell, 617-680-1088
paulkidwell@comcast.net
or
Investors Contact
Stern Investor Relations, Inc.
Christina Tartaglia, 212-362-1200
Christina@sternir.com

Contacts

Media Contact
For Mersana Therapeutics
Paul Kidwell, 617-680-1088
paulkidwell@comcast.net
or
Investors Contact
Stern Investor Relations, Inc.
Christina Tartaglia, 212-362-1200
Christina@sternir.com